Cargando…

Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma

Detalles Bibliográficos
Autores principales:	Ku, Ja Hyeon, Choi, Woonyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039380/ https://www.ncbi.nlm.nih.gov/pubmed/33854979 http://dx.doi.org/10.3389/fonc.2021.656974

Ejemplares similares

Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Editorial: Evidence and emerging option in diagnosis and management of upper tract urothelial carcinomas
por: Liu, Liangren, et al.
Publicado: (2022)

Editorial: Optimal perioperative management of urothelial carcinoma
por: Holzman, Ariane, et al.
Publicado: (2023)

Clinical Significance of Pre-treated Neutrophil-Lymphocyte Ratio in the Management of Urothelial Carcinoma: A Systemic Review and Meta-Analysis
por: Suh, Jungyo, et al.
Publicado: (2019)

Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Editorial: Therapies and influences in urothelial carcinoma
por: Ozgun, G., et al.
Publicado: (2022)

Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
por: Yoon, Hyun Sik, et al.
Publicado: (2019)

High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Increased urinary B2-microglobulin is associated with poor prognosis of upper tract urothelial carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021)

Editorial: Urothelial carcinoma of renal pelvis and ureter, prognosis and recent advances
por: Wu, Shu-Yu, et al.
Publicado: (2023)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study
por: Kim, Hyung Suk, et al.
Publicado: (2020)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

Editorial: Case reports in urothelial cancer
por: Kramer, Mario W.
Publicado: (2023)

Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma
por: Fenton, Sarah E., et al.
Publicado: (2023)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis
por: Banini, Bubu A., et al.
Publicado: (2022)

Editorial: Recent advances in cervical cancer radiotherapy
por: Varlotto, John Michael, et al.
Publicado: (2023)

Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

Upper urinary tract urothelial carcinoma diagnosis by biopsy of a vaginal metastasis
por: Hermi, A., et al.
Publicado: (2022)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans
por: Knapp, Deborah W., et al.
Publicado: (2020)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
por: Adham, Sirin A., et al.
Publicado: (2022)

Editorial: Recent advances of drug resistance research in colorectal cancer therapy
por: Ye, Chenyang, et al.
Publicado: (2022)

Management of infantile hemangiomas: Recent advances
por: Xu, Wei, et al.
Publicado: (2022)

RE: Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors
por: Zhang, Zhao-Hui, et al.
Publicado: (2020)

Editorial: Advances in the Diagnosis and Treatment of Skull Base Tumours
por: Cleere, Eoin F., et al.
Publicado: (2022)

Editorial: Advances in genetics and molecular diagnosis in colorectal cancer
por: Islam, Farhadul, et al.
Publicado: (2023)

Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National university hospital experience
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Recent advances of pathomics in colorectal cancer diagnosis and prognosis
por: Wu, Yihan, et al.
Publicado: (2023)

Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
por: Lavoie, Jean-Michel, et al.
Publicado: (2022)

Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
por: Nguyen, Charles B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q5i47hl9kco8ks9dorcmrk0242